AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 998549
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of pyridoxine supplementation
Trial: 23676940
Drug: SCIT combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCIT combined with standardized treatment for asthma
Trial: 23676940
Drug: Standardized treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized treatment alone
Trial: 9578250
Drug: Patient-controlled propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Patient-controlled propofol administration
Trial: 9578250
Drug: Operator-controlled propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Operator-controlled propofol administration
Trial: 7715982
Drug: Cold-adapted influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold-adapted influenza A reassortant virus vaccine (10^5 or 10^6 TCID50) administered separately from routine immunizations
Trial: 7715982
Drug: Cold-adapted influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold-adapted influenza A reassortant virus vaccine (10^6 TCID50) administered with routine immunizations at 2 and 4 months of age
Trial: 7715982
Drug: Cold-adapted influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold-adapted influenza A reassortant virus vaccine (10^6 TCID50) administered with routine immunizations at 2 and 6 months of age
Trial: 23443221
Drug: Rhodiola rosea
RxNorm normalized name: RHODIOLA ROSEA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhodiola rosea (3 mg·kg(‐1))
Trial: 15531698
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg elemental Fe as (57)Fe-labeled sprinkles added to maize-based porridge
Trial: 15531698
Drug: 45 mg
RxNorm normalized name: lutein 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 mg elemental Fe as (57)Fe-labeled sprinkles added to maize-based porridge
Trial: 15531698
Drug: (58)Fe tracer
RxNorm normalized name: Fe
DrugBank: Ferric cation (DB13949)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (58)Fe tracer (0.2 mg as ferrous citrate) infused intravenously
Trial: 11061523
Drug: Oxytocin (OT)
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin (OT) infusion at 1, 2, or 4 mIU/min for 10 hours
Trial: 11061523
Drug: Dexamethasone (dex;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (dex; 4 mg, iv) followed by OT infusion at 1 mIU/min
Trial: 11061523
Drug: Dexamethasone (dex;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (dex; 4 mg, iv) followed by OT infusion at 2 or 4 mIU/min
Trial: 11061523
Drug: Dexamethasone (dex;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (dex; 4 mg, iv) in obese subjects
Trial: 11061523
Drug: Oxytocin (OT)
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin (OT) infusion at 1, 2, or 4 mIU/min in obese subjects
Trial: 11061523
Drug: Dexamethasone (dex;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (dex; 4 mg, iv) with OT infusion in obese subjects
Trial: 9117220
Drug: Simulated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simulated treatment (placebo-like)
Trial: 10565580
Drug: High-information preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-information preparation condition
Trial: 10565580
Drug: Low-information preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-information preparation condition
Trial: 2439799
Drug: Bisoprolol (BPL)
DrugBank: Bisoprolol (DB00612)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Bisoprolol (BPL) 20 mg
Trial: 2439799
Drug: Atenolol (ATL)
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol (ATL) 100 mg
Trial: 2701823
Drug: EMG biofeedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMG biofeedback treatment
Trial: 2701823
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (routine physiotherapy)
Trial: 31164168
Drug: Daily electronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily electronic patient-reported outcome (PRO) diaries
Trial: 21423758
Drug: G-CSF (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF (10 µg/kg BW)
Trial: 17490568
Drug: Fluid resuscitation
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid resuscitation (250 ml bolus every 15 minutes until ITBVI>850 ml/m(2))
Trial: 2688147
Drug: 200‐mg of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200‐mg of enoxacin twice a day for two days
Trial: 2688147
Drug: 400‐mg of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400‐mg of enoxacin twice a day for two days
Trial: 29282152
Drug: Inspiratory muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory muscle training (50% maximum inspiratory pressure, twice daily for 4 weeks)
Trial: 17109337
Drug: AIDSVAX B/E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AIDSVAX B/E (VaxGen) vaccine
Trial: 15009462
Drug: Oral methionine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral methionine load
Trial: 7848545
Drug: Intra-articular glucocorticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular glucocorticosteroid therapy
Trial: 7848545
Drug: Oral steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral steroids and corticotrophin (adrenocorticotrophic hormone)
Trial: 7848545
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose colchicine
Trial: 7848545
Drug: Uricosuric agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uricosuric agents (e.g., probenecid)
Trial: 3273865
Drug: Cefadroxil 30
RxNorm normalized name: Cefadroxil
DrugBank: Cefadroxil (DB01140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefadroxil 30 mg/kg every 24 hours orally for ten days
Trial: 3273865
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V potassium 15 mg/kg every eight hours orally for ten days
Trial: 25166440
Drug: Phase I
RxNorm normalized name: Nuvelle TS Phase I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase I periodontal treatment + NSAID (20 mg tenoxicam tablet once daily for 10 days)
Trial: 25166440
Drug: Phase I
RxNorm normalized name: Nuvelle TS Phase I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase I periodontal treatment + placebo
Trial: 19660009
Drug: NVP 200
RxNorm normalized name: NVP
DrugBank: Nevirapine (DB00238)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NVP 200 mg b.i.d. plus > or =2 NRTIs and DRV/r 300/100 mg b.i.d.
Trial: 19660009
Drug: NVP 200
RxNorm normalized name: NVP
DrugBank: Nevirapine (DB00238)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NVP 200 mg b.i.d. plus > or =2 NRTIs and DRV/r 400/100 mg b.i.d.
Trial: 19660009
Drug: NVP 200
RxNorm normalized name: NVP
DrugBank: Nevirapine (DB00238)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NVP 200 mg b.i.d. plus > or =2 NRTIs
Trial: 9626901
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of Mg orally per day for 1 month
Trial: 9626901
Drug: No Mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Mg (control group)
Trial: 7833230
Drug: Lansoprazole (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole (60 mg day-1)
Trial: 3046631
Drug: Dilevalol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol (100 mg to 800 mg)
Trial: 30795811
Drug: Multi-component smoking
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-component smoking cessation service package (regular motivation by nurse, monthly piCO+ Smokerlyzer test, assistance from trained family member, optional nicotine replacement gum)
Trial: 20868965
Drug: Remifentanil (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (4 μg/kg IV)
Trial: 18441042
Drug: 30 minutes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 minutes of daily training in sit‐to‐stand and leg strengthening exercises for 30 minutes, on weekdays for two weeks, with a physiotherapy assistant
Trial: 18441042
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received arm therapy
Trial: 18441042
Drug: 30 minutes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 minutes of daily training in sit‐to‐stand
Trial: 15876493
Drug: Local anaesthetic
RxNorm normalized name: Local anaesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anaesthetic solution with morphine (1 mg)
Trial: 15876493
Drug: Standard local
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard local anaesthetic solution (articaine plus epinephrine)
Trial: 10371919
Drug: One randomly
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One randomly selected implant per patient
Trial: 10371919
Drug: Entire material
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entire material of 1,738 implants
Trial: 8676228
Drug: Midazolam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (1 mg/kg) alone
Trial: 8676228
Drug: Midazolam (0.35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.35 mg/kg) and ketamine (5 mg/kg)
Trial: 3963025
Drug: Flurbiprofen 100
RxNorm normalized name: flurbiprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 100 mg per day
Trial: 3067924
Drug: Flurbiprofen 150
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 150 mg per day
Trial: 3963025
Drug: Flurbiprofen 200
RxNorm normalized name: flurbiprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 200 mg per day
Trial: 3963025
Drug: Aspirin 2600
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 2600 mg per day
Trial: 3963025
Drug: Flurbiprofen (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen (all doses)
Trial: 31634871
Drug: Dexmedetomidine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (25 mg slowly injected before surgery)
Trial: 25318186
Drug: Intravitreal injection
RxNorm normalized name: Eylea 2 MG per 0.05 ML Intravitreal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injection of pegaptanib sodium
Trial: 22458638
Drug: Active pindolol
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Active pindolol 20 mg retard daily
Trial: 15625220
Drug: Treatment Initiation
RxNorm normalized name: Otezla 10mg-20mg 28-Day Treatment Initiation Pack Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment Initiation Program (TIP)
Trial: 15625220
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (pharmacotherapy alone)
Trial: 2911999
Drug: Sodium phytate
RxNorm normalized name: sodium phytate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium phytate (2 mg)
Trial: 2911999
Drug: Sodium phytate
RxNorm normalized name: sodium phytate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium phytate (25 mg)
Trial: 2911999
Drug: Sodium phytate
RxNorm normalized name: sodium phytate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium phytate (250 mg)
Trial: 31347612
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg lanadelumab every 2 weeks
Trial: 27989681
Drug: Catheter ablation
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Catheter ablation (CA) plus antiarrhythmic drugs
Trial: 27989681
Drug: Antiarrhythmic drugs
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic drugs alone (control group)
Trial: 21562066
Drug: Traditional and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional and non-traditional risk markers (IL‐1β, IL‐6, TNF‐α, hsCRP, interferon gamma, leptin, IGF‐I, insulin, proinsulin, NT‐proBNP)
Trial: 17236635
Drug: Desflurane/N2O/fentanyl anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desflurane/N2O/fentanyl anesthesia with rocuronium 0.6 mg/kg
Trial: 17236635
Drug: Propofol/N2O/fentanyl anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol/N2O/fentanyl anesthesia with rocuronium 0.6 mg/kg
Trial: 12851747
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg 17beta‐estradiol implant
Trial: 9076645
Drug: Placebo implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo implant
Trial: 8400558
Drug: Mn-DPDP at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mn-DPDP at a concentration of 50 mumol/mL
Trial: 8400558
Drug: Mn-DPDP at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mn-DPDP at a concentration of 10 mumol/mL
Trial: 3511308
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of metoprolol once daily
Trial: 3511308
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg of hydrochlorothiazide once daily
Trial: 24327175
Drug: Dexamethasone (DEX)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DEX) 2 × 2 mg for five consecutive days
Trial: 12186198
Drug: Weekly doses
RxNorm normalized name: selinexor
DrugBank: Selinexor (DB11942)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly doses of 2 x 60 mg iron (one tablet each Friday morning and evening)
Trial: 12186198
Drug: Daily dose
RxNorm normalized name: LENVIMA 8mg Daily Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dose of 1 x 60 mg iron
Trial: 1927616
Drug: Nimodipine IV,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine IV, 2 mg per hour for up to 7 days
Trial: 7011688
Drug: 3.6 g
RxNorm normalized name: ALCOHOL 3.6 g EXTRACORPOREAL CLOTH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.6 g aspirin
Trial: 7011688
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg azapropazone
Trial: 7011688
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and azapropazone together
Trial: 17717604
Drug: Inhaled NO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled NO (iNO; 80 ppm)
Trial: 15479686
Drug: Alicaforsen enema
RxNorm normalized name: Alicaforsen
DrugBank: Alicaforsen (DB06224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alicaforsen enema (4 mg/ml)
Trial: 15479686
Drug: Alicaforsen enema
RxNorm normalized name: Alicaforsen
DrugBank: Alicaforsen (DB06224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alicaforsen enema (2 mg/ml)
Trial: 9311956
Drug: Naturally occurring
RxNorm normalized name: Naturally occurring alkaloid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naturally occurring beta-carotene (BC) derived from Dunaliella bardawil (64 mg tBC, 69 mg 9cBC)
Trial: 27684632
Drug: Warm water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm water intake (200 ml at 98.6°F/37°C in the fourth postoperative hour)
Trial: 23999999
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of the miRNA signature and TNM stage.
Trial: 17206944
Drug: Alpha-tocopherol 600
RxNorm normalized name: (+)-alpha-tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-tocopherol 600 IU/day plus ascorbic acid 500 mg/day (group B)
Trial: 8909662
Drug: i.v. prochlorperazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. prochlorperazine 0.1 mg.kg‐1
Trial: 8909662
Drug: i.m. prochlorperazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. prochlorperazine 0.2 mg.kg‐1
Trial: 8909662
Drug: i.v. ondansetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. ondansetron 0.06 mg.kg‐1
Trial: 31434094
Drug: Interventional AVM
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interventional AVM treatment (surgical resection, endovascular therapy, stereotactic radiosurgery)
Trial: 29574974
Drug: Everolimus 2.25-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 2.25-3 mg BID in transplant patients
Trial: 29574974
Drug: Everolimus 3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 3.75 mg BID for oncological indications
Trial: 24478323
Drug: Exercise program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise program (sensorimotor, endurance, and strength training twice a week for 36 weeks)
Trial: 19171009
Drug: Two or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two or more doses of sulfadoxine-pyrimethamine (SP)
Trial: 19171009
Drug: Each increment
RxNorm normalized name: Urinary concrement solvents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Each increment in number of SP doses
Trial: 17573796
Drug: 32 tablets
RxNorm normalized name: phosphorus 32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 tablets (48 g) of sodium phosphate (NaP)
Trial: 17573796
Drug: 2L polyethylene
RxNorm normalized name: polyethylenes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2L polyethylene glycol (PEG) solution plus 4 (20 mg) bisacodyl tablets
Trial: 15833091
Drug: Topiramate 200
RxNorm normalized name: topiramate 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 200 mg per day
Trial: 15833091
Drug: Topiramate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (100 mg per day)
Trial: 15833091
Drug: Topiramate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (100 or 200 mg per day)
Trial: 11812917
Drug: Epoetin alfa,
RxNorm normalized name: EPOETIN ALFA,RECOMBINANT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin alfa, 150-300 IU/kg or 10,000-20,000 IU, three times weekly
Trial: 11812917
Drug: Epoetin alfa,
RxNorm normalized name: EPOETIN ALFA,RECOMBINANT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin alfa, once-weekly dosing
Trial: 2520419
Drug: Pulsed infrared
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed infrared laser treatment, 12 sessions on alternate days, total energy dose of 5 J each, targeting four painful muscular trigger points and five acupuncture points.
Trial: 2520419
Drug: Placebo treatment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment, 12 sessions on alternate days, identical procedure to the intervention group but with nonoperational laser apparatus.
Trial: 1036663
Drug: Diets containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diets containing proteins (3.0 g of N from rice plus 3.0 g of N from milk)
Trial: 1036663
Drug: Diets containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diets containing proteins (3.0 g of N from rice plus 3.0 g of N from wheat flour)
Trial: 19128713
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of 10 mg/mL ropivacaine hydrochloride with epinephrine (n=19)
Trial: 19128713
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of 2.5 mg/mL bupivacaine with epinephrine (n=20)
Trial: 16501426
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (80 mg/day)
Trial: 16501426
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus heparin (80 mg/day + 5000 IU unfractionated heparin subcutaneously 12 hourly)
Trial: 12871893
Drug: Post-menopausal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Post-menopausal hormone therapy (pHT) regimens including any estrogen, any estrogen plus any progestin, or tibolone
Trial: 12871893
Drug: Any estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any estrogen compound
Trial: 8793701
Drug: Non-pharmacological management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-pharmacological management (dietary therapy, restriction of alcohol consumption, exercise)
Trial: 8793701
Drug: Non-pharmacological management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-pharmacological management (restriction of sodium intake, behavioral therapy)
Trial: 6500764
Drug: Phenylbutazone 300
RxNorm normalized name: phenylbutazone 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylbutazone 300 mg per day
Trial: 6500764
Drug: Ibuprofen 1200
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen 1200 mg per day
Trial: 30478021
Drug: M-CT (mobile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M-CT (mobile cognitive therapy) with minimal therapist support added to treatment as usual (TAU)